GenScript Biotech Amends 2019 and 2021 Restricted Share Unit Schemes

Reuters
2025/12/16
<a href="https://laohu8.com/S/01548">GenScript</a> Biotech Amends 2019 and 2021 Restricted Share Unit Schemes

GenScript Biotech Corporation has announced amendments to its 2019 and 2021 Restricted Share Unit (RSU) Schemes. The updated 2019 RSU Scheme, originally adopted in March 2019, was amended on 21 June 2024. The 2021 RSU Scheme, first adopted in August 2021, was previously amended in May 2022 and has now also been updated as of 21 June 2024. These changes are intended to facilitate the administration and implementation of the schemes for selected participants, including US residents and those subject to US tax.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251216-11956414), on December 15, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10